Covaxin gets DCGI nod to conduct clinical trials on children смотреть онлайн

Описание видео

The Drugs Controller General of India (DCGI) has approved Bharat Biotech’s Covaxin to conduct the Phase 2-3 clinical trials on children aged 2-18 years. Bharat Biotech will conduct the clinical trials on 525 healthy volunteers in the below 18 age group. Watch the video for more information. Рекомендуем Covaxin gets DCGI nod to conduct clinical trials on children посмотреть онлайн видео бесплатно и без регистрации!